Paliperidone palmitate and Hyperprolactinaemia - a phase IV clinical study of FDA data

Summary:

Hyperprolactinaemia is reported as a side effect among people who take Paliperidone palmitate (paliperidone palmitate), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Risperdal, and have Schizophrenia.

The phase IV clinical study analyzes which people have Hyperprolactinaemia when taking Paliperidone palmitate. It is created by eHealthMe based on reports of 2,978 people who have side effects when taking Paliperidone palmitate from the FDA, and is updated regularly.

What is Paliperidone palmitate?

Paliperidone palmitate has active ingredients of paliperidone palmitate. eHealthMe is studying from 2,987 Paliperidone palmitate users. Check the latest studies of Paliperidone palmitate.

What is Hyperprolactinaemia?

Hyperprolactinaemia (abnormally high levels of prolactin in the blood) is found to be associated with 213 drugs and 392 conditions by eHealthMe. Check the latest studies of Hyperprolactinaemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

2,978 people reported to have side effects when taking Paliperidone palmitate.
Among them, 52 people (1.75%) have Hyperprolactinaemia.

Could Paliperidone palmitate cause Hyperprolactinaemia?

Among these 52 people:

How long have people been on Paliperidone palmitate when they have Hyperprolactinaemia? *

What is the gender of people who have Hyperprolactinaemia when taking Paliperidone palmitate? *

female: 50 %
male: 50 %

What is the age of people who have Hyperprolactinaemia when taking Paliperidone palmitate? *

What are other drugs people take besides Paliperidone palmitate? *

What are other side effects people have besides Hyperprolactinaemia? *

Weight Increased: 15 people, 28.85%
Vision Blurred: 8 people, 15.38%
Amenorrhea (absence of a menstrual period in a woman of reproductive age): 8 people, 15.38%
Gynecomastia (enlargement of the gland tissue of the male breast): 8 people, 15.38%
Sedation: 8 people, 15.38%
Galactorrhea (secretion of breast milk in men): 7 people, 13.46%
Hypotension (abnormally low blood pressure): 7 people, 13.46%
Tremor (trembling or shaking movements in one or more parts of your body): 7 people, 13.46%
Headache (pain in head): 7 people, 13.46%
Depression: 7 people, 13.46%

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 35 people, 67.31%
Insomnia (sleeplessness): 7 people, 13.46%
Stress And Anxiety: 4 people, 7.69%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 4 people, 7.69%
Bipolar Disorder (mood disorder): 4 people, 7.69%
Psychotic Disorder: 3 people, 5.77%
Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 3 people, 5.77%
Mania (a state of abnormally elevated or irritable mood): 2 people, 3.85%
Suspiciousness: 1 person, 1.92%
Salivary Hypersecretion (excess saliva secretion): 1 person, 1.92%

* Approximation only. Some reports may have incomplete information.

Do you take Paliperidone palmitate and have Hyperprolactinaemia?

- Check whether Hyperprolactinaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Paliperidone palmitate:

Paliperidone palmitate (2,987 reports)

Browse all side effects of Paliperidone palmitate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperprolactinaemia:

Hyperprolactinaemia (213 drugs)

Browse all the conditions that are associated with Hyperprolactinaemia:

Hyperprolactinaemia (392 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on paliperidone palmitate (the active ingredients of Paliperidone palmitate) and Paliperidone palmitate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.